arrow
C

Chung Mo Nam

department of preventive medicine
H指数:54
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Efficacy of the first-line immune checkpoint inhibitor plus chemotherapy for gastroesophageal cancer: A meta-analysis of phase III trials including unreported PD-L1 subgroups” [Cancer Lett. 623, (2025) 217718]

勘误:“Efficacy of the first-line immune checkpoint inhibitor plus chemotherapy for gastroesophageal cancer: A meta-analysis of phase III trials including unreported PD-L1 subgroups” [Cancer Lett. 623, (2025) 217718]

2025-06-030
PRE
Combination therapy with moderate-intensity atorvastatin and ezetimibe vs. high-intensity atorvastatin monotherapy in patients treated with percutaneous coronary intervention in practice: assessing RACING generalizability
2023-11-104
PRE
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study

nivolumab和紫杉醇二线化学免疫治疗免疫相关生物标志物富集的晚期胃癌: 一项多中心Ib/II期研究

2023-10-315
PRE